Bioceres Crop Solutions Statistics
 Total Valuation
 BIOX has a market cap or net worth of $107.87 million. The enterprise value is $341.82 million.
 Important Dates
 The next confirmed earnings date is Thursday, November 13, 2025, before market open.
 | Earnings Date | Nov 13, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
 BIOX has 62.71 million shares outstanding. The number of shares has decreased by -0.45% in one year.
 | Current Share Class | 62.71M | 
| Shares Outstanding | 62.71M | 
| Shares Change (YoY) | -0.45% | 
| Shares Change (QoQ) | +0.66% | 
| Owned by Insiders (%) | 1.96% | 
| Owned by Institutions (%) | 15.56% | 
| Float | 33.43M | 
Valuation Ratios
  | PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | 0.33 | 
| Forward PS | 0.30 | 
| PB Ratio | 0.35 | 
| P/TBV Ratio | 7.45 | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
 Financial Ratio HistoryEnterprise Valuation
  | EV / Earnings | n/a | 
| EV / Sales | 1.03 | 
| EV / EBITDA | 23.27 | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
  | Current Ratio | n/a | 
| Quick Ratio | n/a | 
| Debt / Equity | 0.79 | 
| Debt / EBITDA | 18.60 | 
| Debt / FCF | n/a | 
| Interest Coverage | -0.12 | 
Financial Efficiency
 Return on equity (ROE) is -15.90% and return on invested capital (ROIC) is -0.27%.
 | Return on Equity (ROE) | -15.90% | 
| Return on Assets (ROA) | n/a | 
| Return on Invested Capital (ROIC) | -0.27% | 
| Return on Capital Employed (ROCE) | n/a | 
| Revenue Per Employee | $856,812 | 
| Profits Per Employee | -$133,162 | 
| Employee Count | 389 | 
| Asset Turnover | n/a | 
| Inventory Turnover | n/a | 
Taxes
 In the past 12 months, BIOX has paid $1.30 million in taxes.
 | Income Tax | 1.30M | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
 The stock price has decreased by -74.89% in the last 52 weeks. The beta is 0.33, so BIOX's price volatility has been lower than the market average.
 | Beta (5Y) | 0.33 | 
| 52-Week Price Change | -74.89% | 
| 50-Day Moving Average | 1.97 | 
| 200-Day Moving Average | 3.94 | 
| Relative Strength Index (RSI) | 46.63 | 
| Average Volume (20 Days) | 1,441,677 | 
Short Selling Information
  | Short Interest | 679,792 | 
| Short Previous Month | 722,154 | 
| Short % of Shares Out | 1.08% | 
| Short % of Float | 2.03% | 
| Short Ratio (days to cover) | 0.69 | 
Income Statement
 In the last 12 months, BIOX had revenue of $333.30 million and -$51.80 million in losses. Loss per share was -$0.82.
 | Revenue | 333.30M | 
| Gross Profit | 130.20M | 
| Operating Income | -2.70M | 
| Pretax Income | -53.90M | 
| Net Income | -51.80M | 
| EBITDA | 14.69M | 
| EBIT | -2.70M | 
| Loss Per Share | -$0.82 | 
 Full Income StatementBalance Sheet
 The company has $39.35 million in cash and $273.30 million in debt, giving a net cash position of -$233.96 million or -$3.73 per share.
 | Cash & Cash Equivalents | 39.35M | 
| Total Debt | 273.30M | 
| Net Cash | -233.96M | 
| Net Cash Per Share | -$3.73 | 
| Equity (Book Value) | 344.98M | 
| Book Value Per Share | 4.92 | 
| Working Capital | n/a | 
 Full Balance SheetMargins
 Gross margin is 39.06%, with operating and profit margins of -0.81% and -15.54%.
 | Gross Margin | 39.06% | 
| Operating Margin | -0.81% | 
| Pretax Margin | -16.17% | 
| Profit Margin | -15.54% | 
| EBITDA Margin | 4.41% | 
| EBIT Margin | -0.81% | 
| FCF Margin | n/a | 
Dividends & Yields
 BIOX does not appear to pay any dividends at this time.
 | Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | 0.45% | 
| Shareholder Yield | 0.45% | 
| Earnings Yield | -48.02% | 
| FCF Yield | n/a | 
 Analyst Forecast
 The average price target for BIOX is $4.50, which is 161.63% higher than the current price. The consensus rating is "Buy".
 | Price Target | $4.50 | 
| Price Target Difference | 161.63% | 
| Analyst Consensus | Buy | 
| Analyst Count | 3 | 
| Revenue Growth Forecast (5Y) | n/a | 
| EPS Growth Forecast (5Y) | n/a | 
 Stock ForecastsFair Value
 There are several formulas that can be used to estimate the intrinsic value of a stock.
 | Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
 This stock does not have any record of stock splits.
 | Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
  | Altman Z-Score | n/a | 
| Piotroski F-Score | n/a |